Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04879927 · ClinicalTrials.gov registry record · NA

Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement

A NA study of Breast Cancer and Lung Cancer, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT04879927 is a NA study of Breast Cancer and Lung Cancer that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 125 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04879927, a NA study of Breast Cancer and Lung Cancer, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to understand how screening for patient resource needs followed by customized resource matching can improve outcomes for adults with breast, lung or gastrointestinal cancer.

Interventions

  • OTHER Usual Care
  • OTHER Resource Matching

Study Locations (1)

Massachusetts

  • Dana Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2021-05-17
Est. Completion 2023-04-01
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT04879927

The ClinicalTrials.gov registry entry for NCT04879927 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT04879927 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04879927 about?

NCT04879927 is a clinical study titled "Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement". The purpose of this research is to understand how screening for patient resource needs followed by customized resource matching can improve outcomes for adults with breast, lung or gastrointestinal cancer.

What is the current status of trial NCT04879927?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2021-05-17. Estimated completion is 2023-04-01.

What conditions does trial NCT04879927 study?

This clinical trial studies the following conditions: Breast Cancer, Lung Cancer, Gastrointestinal Cancer.

What interventions are being tested in trial NCT04879927?

The interventions under investigation include: Usual Care (OTHER), Resource Matching (OTHER).

Who is sponsoring clinical trial NCT04879927?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04879927 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.